Literature DB >> 10616820

Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States).

C R Morris1, K P Snipes, R Schlag, W E Wright.   

Abstract

OBJECTIVES: Data from the California Cancer Registry were used to model the effect of race/ethnicity, census-derived socioeconomic status (SES), age, year, and stage at diagnosis on prostatectomy utilization in men diagnosed with prostate cancer from 1990 through 1993. Treatment received was compared with the National Cancer Institute's Physician Data Query (PDQ) to evaluate concordance.
METHODS: Odds ratios (OR) and 95% confidence intervals (CI) were estimated to assess the likelihood of (a) receiving a prostatectomy and (b) receiving a treatment in concordance with the PDQ. Non-concordance was defined as a prostatectomy performed on a patient who was either diagnosed with AJCC stage III or IV prostate cancer, or was older than 70 years. All other treatments were considered compliant with the PDQ.
RESULTS: Regardless of the stage at diagnosis, men who were younger and lived in a neighborhood with higher income and education levels were the most likely to receive a prostatectomy as opposed to other treatments. Black men were the least likely to be treated with prostatectomy (OR = 0.6, CI = 0.5-0.6), and the differential was evident within all income levels examined. With respect to the PDQ, black men were 1.4 times more likely to receive concordant treatment than white men (OR = 1.4, CI = 1.3-1.5).
CONCLUSIONS: California black men are receiving less aggressive treatment (that is more concordant with the PDQ) when diagnosed with prostate cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10616820     DOI: 10.1023/a:1008951009959

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  14 in total

1.  Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Authors:  Vickie L Shavers; Martin L Brown; Arnold L Potosky; Carrie N Klabunde; W W Davis; Judd W Moul; Angela Fahey
Journal:  J Gen Intern Med       Date:  2004-02       Impact factor: 5.128

2.  African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.

Authors:  Augustine C Obirieze; Ambria Moten; Delenya Allen; Chiledum A Ahaghotu
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-16

3.  Are HIV-infected men vulnerable to prostate cancer treatment disparities?

Authors:  Adam B Murphy; Ramona Bhatia; Iman K Martin; David A Klein; Courtney M P Hollowell; Yaw Nyame; Elodi Dielubanza; Chad Achenbach; Rick A Kittles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-25       Impact factor: 4.254

4.  Racial Differences in Prostate Cancer Treatment: The Role of Socioeconomic Status.

Authors:  Megan Watson; David Grande; Archana Radhakrishnan; Nandita Mitra; Katelyn R Ward; Craig Evan Pollack
Journal:  Ethn Dis       Date:  2017-07-20       Impact factor: 1.847

5.  Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.

Authors:  Arica White; Ann L Coker; Xianglin L Du; Katherine S Eggleston; Melanie Williams
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

6.  Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population.

Authors:  G M Monawar Hosain; Maureen Sanderson; Xianglin L Du; Wenyaw Chan; Sara S Strom
Journal:  Am J Mens Health       Date:  2012-03-13

7.  Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Authors:  Maria J Schymura; Amy R Kahn; Robert R German; Mei-Chin Hsieh; Rosemary D Cress; Jack L Finch; John P Fulton; Tiefu Shen; Erik Stuckart
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

8.  Healthcare access, socioeconomic factors and late-stage cancer diagnosis: an exploratory spatial analysis and public policy implication.

Authors:  Fahui Wang; Lan Luo; Sara McLafferty
Journal:  Int J Public Pol       Date:  2009-12-28

9.  Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients.

Authors:  Ingrid Oakley-Girvan; Laurence N Kolonel; Richard P Gallagher; Anna H Wu; Anna Felberg; Alice S Whittemore
Journal:  Am J Public Health       Date:  2003-10       Impact factor: 9.308

10.  Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database.

Authors:  Lionel L Bañez; Martha K Terris; William J Aronson; Joseph C Presti; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.